Moses Raj
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Pittsburgh, PA 15212Call today!
About
Moses Raj
Moses S. Raj, MD, is a medical oncologist with AHN Cancer Institute, specializing in providing compassionate and empathetic oncological care, with a focus on lung cancer. He has expertise in treating gastrointestinal, pancreatic, and hepatobiliary malignancies. Dr. Raj went to medical school at Guntur Medical College in Guntur, India. He did his residency at Metrowest Medical Center in Framingham, Massachusetts and did his fellowship in hematology and oncology at University of Iowa Hospitals in Iowa City, Iowa. Dr. Raj is certified by the American Board of Internal Medicine in Medical Oncology and Hematology and is affiliated with the American Society of Clinical Oncology. He sees patients ages 18 and older.
Primary Specialty
Oncologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Male
Education
NTR University of Health Sciences Vijayawada Guntur Medical College
Training
MetroWest Medical Center, Ohio Valley Medical Center, University of Iowa Hospitals and Clinics
Certification
American Board of Internal Medicine-Medical Oncology
Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Allegheny General Hospital, Allegheny Valley Hospital, Canonsburg Hospital, West Penn Hospital, Wexford Hospital, Forbes Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Languages
English
Business Hours
Monday:9:00 AM - 4:00 PM
Tuesday:9:00 AM - 4:00 PM
Wednesday:9:00 AM - 4:00 PM
Thursday:9:00 AM - 4:00 PM
Friday:9:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!